Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant - Related Studies

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant (GLOBAL)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2009 by Gruppo Italiano Trapianto di Midollo Osseo.
Recruitment status was Active, not recruiting

Study NCT00354120 Information provided by Gruppo Italiano Trapianto di Midollo Osseo

First Received on July 19, 2006. Last Updated on October 30, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Alemtuzumab

More general drug interventions related to this trial

Sponsors listed in this trial